Skip to main content

Exclusive negotiations for the acquisition of an European spinal entity

Written by Customer Service on . Posted in Mergers And Acquisitions.

Press release                                                                                        Ecully, 18 March 2021 – 6 p.m.
Exclusive negotiations for the acquisition
of a start-up in the field of spinal surgerySpineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.With its founder having over 25 years’ experience in the spine field, the company has a line of products for spinal fusions that it sells directly in France and via distributors internationally.In line with the Group’s growth strategy, this acquisition will allow Spineway to consolidate its product range and strengthen its positions in Europe by making a wider variety of operating techniques with added value possible for spinal surgeons.Positioned on market segments representing 90% of the use of spinal-surgery implants, this company has strong growth potential in the current competitive environment and expects its revenue to exceed €4M in three years1.The project remains subject to several conditions precedent, in particular audits resulting in satisfactory reports. This acquisition would be financed in cash and have the start-up’s team be integrated within the Group.This acquisition should be finalized by the end of May.Upcoming: 15 April 2021 – Publication of Q1 2021 revenueSPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.comThis press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 – ALSPWContacts:
1 Not audited
AttachmentSPW_CP_LOI_VD_GB

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.